DOI: 10.1039/C5RA21183B
Page 5 of 8
Journal Name
RSC Advances
ARTICLE
A Schlenk tube containing imidazole alcohol (1a or 1b, 5 13C NMR (100 MHz, DMSO): 160.5, 152.7, 136.3, 122.9,
mmol) and 2-bromopyridine (3 mL) was heated at 150°C for 72 122.8, 119.9, 63.4, 62.4, 38.5, 24.4, 23.2, 22.0 ppm. MS Calcd.
h. The mixture was then cooled to room temperature and added for C13H19ClN4O, 282.1. Found: ESI-MS, m/z: 247.1 [M-Cl]+.
to diethyl ether (30 mL) dropwise, leading to the formation of
(S)-1-(1-hydroxy-3-phenylpropan-2-yl)-3-(pyrimidin-2-
deep yellow precipitate, which was then collected and purified yl)-1H-imidazol-3-ium chloride (2d). Yellow crystals (1.42 g,
1
by flash chromatography (silica, CH2Cl2/EtOH = 15/1~8/1, v/v) 90 %). Mp: 128-130 °C. H NMR (400 MHz, DMSO): 10.27
to produce the pure products.
(s, 1H, CH in imidazole), 9.05 (d, 2H, J = 4.9 Hz, CH in
(
S
)-1-(1-hydroxy-4-methylpentan-2-yl)-3-(pyridin-2-yl)-
pyrimidine), 8.49 (t, 1H, J = 1.7 Hz, CH in imidazole), 8.29 (t,
1H-imidazol-3-ium bromide (2a). Viscous oil (1.42 g, 87%). 1H, J = 1.6 Hz, CH in imidazole), 7.78 (t, 1H, J = 4.9 Hz, CH
1H NMR (400 MHz, DMSO):
in pyrimidine), 7.28 (d, 4H, J = 4.4 Hz, PhH), 7.20-7.17 (m, 1H,
imidazole), 8.68-8.66 (m, 1H, CH in pyridine), 8.62 (t, J = 1.8 PhH), 5.68 (t, 1H, J = 5.4 Hz, CH2OH), 5.10-5.03 (m, 1H,
Hz, 1H, CH in imidazole), 8.26-8.22 (m, 1H, CH in pyridine), NCH), 3.91-3.80 (m, 2H, CH2OH), 3.41-3.32 (m, 2H, PhCH2)
8.21 (t, J = 1.8 Hz, 1H, CH in imidazole), 8.11 (d, J = 8.3 Hz, ppm. 13C NMR (100 MHz, DMSO): 160.5, 152.5, 136.9,
1H, CH in pyridine), 7.68-7.65 (m, 1H, CH in pyridine), 5.26 136.1, 129.4, 129.0, 127.3, 123.3, 122.9, 119.6, 65.0, 62.5, 36.0
(bs, 1H, CH2OH), 4.64-4.60 (m, 1H, NCH), 3.77-3.70 (m, 2H, ppm. MS Calcd. for C16H17ClN4O, 316.1. Found: ESI-MS, m/z:
CH2OH), 1.97-1.91 (m, 1H, CH2CH(CH3)2), 1.70-1.63 (m, 1H, 281.1 [M-Cl]+.
CH2CH(CH3)2), 1.45-1.38 (m, 1H, CH2CH(CH3)2), 0.93 (d, 3H,
Synthesis of palladium complexes (3a-d)
J = 6.5 Hz, CH2CH(CH3)2), 0.89 (d, 1H, J = 6.6 Hz,
13
CH2CH(CH3)2) ppm.
A mixture of imidazolium salt (2a, 2b, 2c or 2d, 1.0 mmol),
146.9, 141.0, 135.2, 125.7, 122.8, 120.1, 114.8, 63.5, 62.3, 38.6, Pd(OAc)2 (1.0 mmol, 0.22 g) in CH2Cl2 (10 mL) was stirred at
24.4, 23.2, 22.0 ppm. MS Calcd. for C14H20BrN3O, 325.1. room temperature for 12 h. The solvent was then evaporated
Found: ESI-MS, m/z: 246.08 [M-Br]+.
)-1-(1-hydroxy-3-phenylpropan-2-yl)-3-(pyridin-2-yl)-
and purification of the residue by column chromatography
(
S
1H-imidazol-3-ium bromide (2b). Yellow crystals (1.35 g, produced the pure palladium complexes 3a-d
75 %). Mp: 148-150 °C . H NMR (400 MHz, DMSO): 10.17
.
1
3a. Yellow solids (0.20 g, 39%). 1H NMR (400 MHz,
(s, 1H, CH in imidazole), 8.65 (d, 1H, J = 4.8 Hz, CH in DMSO): 9.44 (s, 1H, CH in pyridine), 8.46 (d, 1H, J = 2.2 Hz,
pyridine), 8.54 (t, 1H, J = 1.7 Hz, CH in imidazole), 8.24-8.20 CH in imidazole), 8.40-8.36 (m, 1H, CH in pyridine), 8.18 (d,
(m, 1H, CH in pyridine), 8.18 (t, J =1.7 Hz, 1H, CH in 1H, J = 8.2 Hz, CH in pyridine), 7.78 (d, 1H, J = 2.3 Hz, CH in
imidazole) 8.06 (d, 1H, J = 8.2 Hz, CH in pyridine), 7.66-7.63 imidazole), 7.62 (t, 1H, J = 7.0 Hz, CH in pyridine), 6.25 (bs,
(m, 1H, CH in pyridine), 7.30-7.20 (m, 5H, PhH), 5.36 (t, 1H, J 1H, NCH), 5.01 (t, 1H, J = 5.2 Hz, CH2OH), 3.70-3.60 (m, 2H,
= 5.6 Hz, CH2OH), 4.90-4.87 (m, 1H, NCH), 3.86-3.82 (m, 2H, CH2OH), 1.90-1.82 (m, 1H, CH2CH(CH3)2), 1.64-1.57 (m, 1H,
CH2OH), 3.32-3.26 (m, 2H, PhCH2) ppm. 13C NMR (100 MHz, CH2CH(CH3)2), 1.41-1.35 (m, 1H, CH2CH(CH3)2), 0.95 (d, 3H,
DMSO): 149.7, 146.7, 141.1, 136.9, 135.0, 129.4, 129.1, J = 6.5 Hz, CH2CH(CH3)2), 0.89 (d, 3H, J = 6.5 Hz,
127.3, 125.8, 123.2, 119.7, 114.7 ppm. MS Calcd. for CH2CH(CH3)2) ppm. 13C NMR (100 MHz, DMSO): 151.8,
C17H18BrN3O M+, 359.1. Found: ESI-MS, m/z: 280.1 [M-Br]+.
150.8, 143.4, 123.6, 122.6, 117.5, 112.9, 64.2, 59.3, 30.1, 24.7,
23.4, 22.8 ppm. Anal Cacld for C14H19Br2N3OPd (511.55): C,
32.87; H, 3.74; N, 8.21. Found: C, 32.68; H, 3.56; N, 8.42.
3b. Yellow solids (0.24 g, 44%). 1H NMR (400 MHz,
Synthesis of pyrimidine hydroxyalkyl di-functionalized
imidazolium chlorides (2c-d)
A Schlenk tube containing imidazole alcohol (1a or 1b, 5 DMSO): 9.40 (s, 1H, CH in pyridine), 8.42 (d, 1H, J = 1.6 Hz,
mmol), 2-chloropyrimidine (6 mmol, 0.69 g) and toluene (15 CH in imidazole), 8.37 (t, 1H, J = 8.2 Hz, CH in pyridine), 8.13
mL) was heated at 110 °C for 72 h. The mixture was then (d, 1H, J = 8.2 Hz, CH in pyridine), 7.91 (d, 1H, J = 2.0 Hz, CH
cooled to room temperature. The deep yellow precipitate in imidazole), 7.61 (t, 1H, J = 6.6 Hz, CH in pyridine), 7.34-
formed was then collected and purified by flash 7.26 (m, 4H, PhH), 7.18 (t, 1H, J = 7.3 Hz, PhH), 6.55 (bs, 1H,
chromatography (silica, CH2Cl2/EtOH = 20/1~8/1, v/v) to NCH), 5.12 (t, 1H, J = 5.0, CH2OH), 3.75-3.65 (m, 2H,
produce the pure products.
)-1-(1-hydroxy-4-methylpentan-2-yl)-3-(pyrimidin-2-
CH2OH), 3.20 (d, 2H, J = 7.9 Hz, C6H5CH2) ppm. 13C NMR
(100 MHz, DMSO): 151.7, 143.4, 137.4, 129.6, 128.8, 127.0,
(
S
yl)-1H-imidazol-3-ium chloride (2c). Yellow crystals (1.12 g, 123.7, 122.7, 117.4, 112.8, 68.9, 63.0, 56.3, 36.7 ppm. Anal
1
79 %). Mp: 184-186 °C. H NMR (400 MHz, DMSO): 10.34 Cacld for C17H17Br2N3OPd (545.56): C, 37.43; H, 3.14; N, 7.70.
(s, 1H, CH in imidazole), 9.08 (d, J = 4.9 Hz, 2H, CH in Found: C, 37.28; H, 2.97; N, 7.89.
pyrimidine), 8.55 (t, J = 1.8 Hz, 1H, CH in imidazole), 8.22 (t,
3c. Yellow solids (0.18 g, 42%). 1H NMR (400 MHz,
J = 1.7 Hz, 1H, CH in imidazole), 7.79 (t, J = 4.9 Hz, 1H, CH DMSO): 9.44 (s, 1H, CH in pyrimidine), 9.07 (s, 1H, CH in
in pyrimidine), 5.47 (t, J = 5.4 Hz, 1H, CH2OH ), 4.75-4.71 (m, pyrimidine), 8.14 (d, 1H, J = 2.3 Hz, CH in imidazole), 7.75 (d,
1H, NCH), 3.68-3.77 (m, 2H, CH2OH), 1.99-1.92 (m, 1H, 1H, J = 2.4 Hz, CH in imidazole), 7.72 (t, 1H, J = 5.3 Hz, CH
CH2CH(CH3)2), 1.67-1.60 (m, 1H, CH2CH(CH3)2), 1.43-1.36 in pyrimidine), 6.11-6.07 (m, 1H, NCH), 5.02 (t, 1H, J = 5.0 Hz,
(m, 1H, CH2CH(CH3)2), 0.93 (d,
J = 6.5 Hz, 3H, CH2OH), 3.65 (t, 2H, J = 4.6 Hz, CH2OH), 1.89-1.82 (m, 1H,
CH2CH(CH3)2), 0.88 (d, J = 6.6 Hz, 3H, CH2CH(CH3)2)) ppm. CH2CH(CH3)2), 1.62-1.55 (m, 1H, CH2CH(CH3)2), 1.39-1.34
This journal is © The Royal Society of Chemistry 2012
J. Name., 2012, 00, 1-3 | 5